The discovery and characterization of peripheral signals that regulate food intake and energy balance dates back over 50 years. Beginning with the 'glucostatic' and 'lipostatic' hypotheses, nutrients were considered strong candidates that could 'tell' the brain the state of satiety (glucose) or overall energy stores (fat), so that food intake and energy expenditure could be regulated to maintain energy balance.
lipostatic hypothesis remains as a central concept in our understanding of the regulation of energy balance. This is based on the key observations that (a) insulin is secreted from the pancreas in direct proportion to fat stores and provides a signal to the brain to initiate long-term changes in energy expenditure and food intake 3 and (b) the peptide hormone leptin is released from adipose tissue itself, and defects in either the production or the signalling of leptin lead to obesity. 4 The glucostatic hypothesis received validation with the discovery of glucose-sensitive neurons in the hypothalamic regions involved in the control of energy balance. 5, 6 Over the years, other nutrient-based hypotheses were developed and the existing ones were modified, but none of these were completely capable of explaining the shortterm control of food intake or certain aspects of long-term energy balance. In the early 1970s, Gibbs et al. 7 found a gastrointestinal hormone, cholecystokinin (CCK), that produced satiety in rats. This discovery heralded the era of the 'gut hormones' as regulators of both food intake and energy balance. We now recognize more than 20 gut-derived peptides and lipid mediators are involved in aspects of energy homeostasis. 11 He illustrates how enteroendocrine peptides are released in sequence along the length of the gut and across the duration of a meal. These peptides regulate both the initiation of a meal and its termination. There are a multitude of anorexigenic peptide signals released from the gut. Moran highlights how these act over the course of a meal and where in the gut they are released from. Remarkably, we know only one peptide that is capable of initiating meals, ghrelin. 14, 15 Blood levels of ghrelin rise before meal ingestion and rapidly decline after a meal. Ghrelin is primarily released from enteroendocrine cells in the stomach, but how this is triggered remains to be determined. We know considerably more about the factors that inhibit the release of ghrelin. 14, 15 Initially it seemed as if ghrelin release was entrained to meal patterns, but more recent studies have shown that ghrelin is released preprandially in humans who eat voluntarily and are deprived of time cues. Ghrelin has therefore been proposed as a hunger signal. If this is the case, then administration of a ghrelin antagonist would be expected to reduce food intake. This was shown to be the case, 16 and interestingly, in a recent study, it took 10 days for animals to compensate for the loss of ghrelin. 17 The magnitude of the reduction of food intake was substantial, being more than 25% over a few days, which reached a maximum of 50% before adaptation occurred. Although these data suggest that other orexigenic signals exist, it is not clear whether these are true hunger signals, and whether they are central or peripheral in origin. Important potential candidates as peripheral orexigens are the endocannabinoids,which are lipid mediators that stimulate appetite and energy conservation through activation of cannabinoid (CB) 1 receptors. 18 These mediators are made 'on demand' in the gut and elsewhere in the periphery, but also centrally. Gomez et al. 19 provided strong evidence that cannabinoids act in the periphery to regulate food intake and showed that the levels of the endocannabinoid anandamide in the ileum rise substantially in food-deprived rats. However, it was not shown whether anandamide levels varied over the course of the feeding cycles of rats. Furthermore, Kirkham et al. 20 have shown similar rises in anandamide in the limbic forebrain, but not the hypothalamus, after food deprivation. They also observed striking elevations in another endocannabinoid, 2-arachidonoyl glycerol (2-AG), in both the forebrain and hypothalamus in food-deprived rats, as well as reductions in 2-AG in the hypothalamus of fed animals. These data implicate central endocannabinoids in food intake regulation. Therefore, it
has not yet been conclusively shown that peripherally released endocannabinoids contribute to the initiation of food intake under physiological conditions. What has emerged recently is the integrative role vagal afferents play in signalling from the gut to the brain and how peptide and lipid mediators may interact at the level of the vagus nerve. 21 The cell bodies of the vagal afferents in the nodose ganglion express receptors for many of the peripheral satiety peptides and also the CB 1 receptor. 22 The expression of CCK 1 receptors in the nodose ganglion is not altered by fasting, whereas fasting upregulates CB 1 receptor expression. Interestingly, feeding downregulates CB 1 receptor expression through activation of CCK 1 receptors, as this effect was abolished by a CCK 1 receptor antagonist. CCK is released from enteroendocrine cells of the proximal intestine in response to meals and, as noted above, is the most welldocumented satiety factor from the gut. 8, 9 Recently, it was discovered that vagal afferents also express receptors for ghrelin, and that these receptors are present on the same neurons as the CB 1 and CCK 1 receptors. 23 Activation of the ghrelin receptor prevented the downregulation of the CB 1 receptors by CCK. This illustrates an additional role for ghrelin in modulating the expression of receptors for another orexigen. These observations lead to further questions regarding the nature of the vagal afferent signals and whether anorexigenic peptides similarly potentiate each other's actions. Gut peptides, released in response to luminal nutrients, signal short-term satiety, meal patterns and long-term energy balance. 8, 9 How these meal-stimulated signals are integrated with the adiposity signalling that occurs over a longer time course remains to be understood. Harvey Grill and Matthew Hayes give us some important insights into the role of the caudal brainstem as a site of integration. 12 They used chronic decerebrate rats to define the brainstem as sufficient to mediate the anorexigenic and gastric effects of an analog of the hormone glucagon-like peptide-1 administered into the 4th ventricle. These interesting results highlight the problem of identifying specific brain regions that contribute to specific feeding responses. However, using this model, Grill and his colleagues have shown a striking capability of the caudal medulla to respond to a range of gut hormones and meal signals, with maintained sensitivity in the absence of forebrain connections. 24 This approach does have limitations; although it shows the sufficiency of the caudal brainstem, it does not allow one to determine its role when there is an intact neuraxis. With the development of novel adenoviral vector technologies that utilize unique promoter sequences to target cells of interest, focused 'lesions' or the expression of new molecules can be accomplished in intact preparations.
In their paper, Grill and Hayes 12 also provide evidence that the caudal brainstem is a potential site of integration of gut and adipose tissue signalling. They show that leptin can amplify the inhibitory actions of gastric distension or gastric nutrient infusions on food intake and that these responses occur in the nucleus of the solitary tract (NTS). Though leptin can be made in the gut, the major source is the adipocyte. The NTS is now well recognized to have the capacity to integrate peripheral signals coming from the gut. 21, 25 What is now emerging as well is that it has the capacity to integrate descending information from the hypothalamus, and likely other forebrain regions. 25, 26 This places it as a critical centre of energy homeostasis and probably deserving of the same status as the hypothalamus as a homeostatic feeding centre in the brain. In the final article in this section, Ferguson and his colleagues convince us that sensory circumventricular organs (CVOs) deserve more attention as 'windows' to the brain centres involved in energy balance than they have received to date. 13 These are small regions of the brain that do not have the normal structure of the blood-brain barrier and therefore lie 'outside' of the brain in terms of their ability to respond to circulating factors present in the blood stream. 27 In a series of elegant studies they show the capacity of the subfornical organ and the area postrema, two important CVOs, to respond to both gut peptides and the adipocytokine adiponectin. 13 The CVOs express a huge range of receptors for peptides, whose physicochemical properties prevent them from accessing other regions of the brain directly. 27 They also possess receptors for ion channels, steroids, lipid mediators and other substances and have extensive projections to brain regions involved in energy homeostasis and so are wellpositioned to respond to circulating factors and initiate appropriate central responses. 27 Timofeeva and colleagues 28 recently illustrated how CVOs might participate in feeding responses. They measured the activation of brain regions in response to refeeding after a fast, using the expression of c-fos as a marker of neuronal activation. Combining c-fos expression with selective lesions, they showed that the activation of hypothalamic nuclei depended on an intact organum vasculosum of the lamina terminalis, a sensory CVO in the forebrain. In contrast, activation of brainstem nuclei and the central nucleus of the amygdala required an intact vagus nerve. 28 These results illustrate the potential for the sensory CVOs to work in concert with the more established energy balance signalling pathways. Direct evidence for the role of the CVOs in energy homeostasis has yet to be conclusively shown. This is because the techniques used to ablate them rarely spare underlying tissues completely and the complicating factors, such as altered fluid intake, associated with their loss confound interpretation of these data. Nevertheless, lesioning of the area postrema leads to altered food consumption and chronic reductions in body weight, through what appears to be an alteration in defended or 'set-point' body weight. [29] [30] [31] In addition, lesioning this CVO limits the ability of some anorectic gut peptides such as amylin and CCK to inhibit food intake. 32, 33 There is no question that defence of the set-point of body weight is the reason why dieting typically fails to produce sustained weight loss in obese individuals. No one neuroanatomical location appears to control the set-point, just as no one peptide or hormone controls food intake. Perhaps the CVOs are part of a network of sites in the homeostatic control of food intake and energy balance that contribute to setting an 'ideal' body weight. Together with the hypothalamus and brainstem, activity in the CVOs ensures that body weight is maintained in the face of environmental challenges. The brain-gut-adipose tissue axis is central to the regulation and maintenance of body weight and food intake. As the papers following this perspective illustrate, substantial progress has been made in understanding the elements of this axis, but we are a long way yet from fully appreciating the subtle and complex nature of the peripheral signalling systems of satiety and the homeostatic control of food intake and energy balance.
